Published in Health Business Week, June 12th, 2009
In the Phase I trial, 4SC 201 was orally administered to 18 patients and was applied in therapy cycles, consisting of a once daily oral dose over five consecutive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week